Publications by authors named "David N Rush"

Claim this Profile
C
Corrigendum to "HLA-DQ heterodimer mismatch as a predictor of post-transplant alloimmunity and allograft survival". [Hum. Immunol. 86 (2025) 111345].
Emmett Tsz Yeung Wong, Robert Balshaw, Ian W Gibson, Julie Ho, Jamie Shaw, David N Rush

Hum Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DQ heterodimer mismatch as a predictor of post-transplant alloimmunity and allograft survival.
Emmett Tsz Yeung Wong, Robert Balshaw, Ian W Gibson, Julie Ho, Jamie Shaw, David N Rush

Hum Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Five-Year Prospective, Randomized, Open-Label Study of Standard-Dose Versus Low-Dose Prolonged-Release Tacrolimus With or Without Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker Post Kidney Transplantation.
Patricia M Campbell, Marcelo Cantarovich, Azim Gangji, Isabelle Houde, Anthony M Jevnikar, David N Rush

Clin Transplant· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients.
Christie Rampersad, Chris Wiebe, Robert Balshaw, Jared Bullard, Ian W Gibson, David N Rush

Clin Transplant· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of Epstein-Barr Virus Chronic High Viral Load in Kidney Transplant Recipients.
Christie Rampersad, Chris Wiebe, Robert Balshaw, Jared Bullard, Armelle Perez Cortes Villalobos, David N Rush

Transplant Direct· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A rational approach to guide cost-effective de novo donor-specific antibody surveillance with tacrolimus immunosuppression.
Chris Wiebe, Rob Balshaw, Ian W Gibson, Julie Ho, Jamie Shaw, David N Rush

Am J Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The negative impact of T cell-mediated rejection on renal allograft survival in the modern era.
Christie Rampersad, Robert Balshaw, Ian W Gibson, Julie Ho, Jamie Shaw, David N Rush

Am J Transplant· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A noninferiority design for a delayed calcineurin inhibitor substitution trial in kidney transplantation.
Peter W Nickerson, Robert Balshaw, Chris Wiebe, Julie Ho, Ian W Gibson, David N Rush

Am J Transplant· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for the alloimmune basis and prognostic significance of Borderline T cell-mediated rejection.
Chris Wiebe, David N Rush, Ian W Gibson, Denise Pochinco, Patricia E Birk

Am J Transplant· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report.
Christie Rampersad, James Shaw, Ian W Gibson, Chris Wiebe, David N Rush

Am J Kidney Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity-based Protein Profiling Approaches for Transplantation.
Mario Navarrete, John A Wilkins, Ying Lao, David N Rush, Peter W Nickerson

Transplantation· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
Chris Wiebe, Vasilis Kosmoliaptsis, Denise Pochinco, Ian W Gibson, Julie Ho, David N Rush

Am J Transplant· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts.
Sandra M Cockfield, Sam Wilson, Patricia M Campbell, Marcelo Cantarovich, Azim Gangji, David N Rush

Am J Transplant· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical Inflammation in Renal Transplantation.
David N Rush, Ian W Gibson

Transplantation· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre randomised controlled trial protocol of urine CXCL10 monitoring strategy in kidney transplant recipients.
Julie Ho, Atul Sharma, Kristine Kroeker, Robert Carroll, Sacha De Serres, David N Rush

BMJ Open· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carpe diem-Time to transition from empiric to precision medicine in kidney transplantation.
Chris Wiebe, Julie Ho, Ian W Gibson, David N Rush, Peter W Nickerson

Am J Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant ATR antibodies correlate with early allograft rejection.
Alison J Gareau, Chris Wiebe, Denise Pochinco, Ian W Gibson, Julie Ho, David N Rush

Transpl Immunol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development.
Chris Wiebe, David N Rush, Thomas E Nevins, Patricia E Birk, Tom Blydt-Hansen

J Am Soc Nephrol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclinical Antibody-Mediated Rejection.
Manuel Arias, Daniel Serón, Ignacio Herrero, David N Rush, Chris Wiebe

Transplantation· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome.
Patricia Hirt-Minkowski, David N Rush, Ang Gao, Helmut Hopfer, Chris Wiebe

Transplantation· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10.
Julie Ho, Atul Sharma, Rupasri Mandal, David S Wishart, Chris Wiebe, David N Rush

Transplant Direct· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury.
Julie Ho, David N Rush, Oleg Krokhin, Mihaela Antonovici, Ang Gao

Transplantation· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The perils of immunosuppression minimization: lessons from protocol biopsies of renal allografts.
David N Rush, Ian W Gibson

Curr Opin Nephrol Hypertens· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels.
Patricia Hirt-Minkowski, Julie Ho, Ang Gao, Patrizia Amico, Michael T Koller, David N Rush

Transplant Direct· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary biomarkers of renal transplant outcome.
Julie Ho, David N Rush, Peter W Nickerson

Curr Opin Organ Transplant· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis